NMPA AnPac Bio Developing Multi-Cancer Testing Device Based on Biophysical Properties of Blood Components Premium The device uses the Chinese-American company's "cancer differentiation analysis" technology and may enable earlier, more robust cancer detection. AnPac Bio Files Multi-Cancer Detection Device for Registrational Testing With China's NMPA The company hopes to begin clinical testing of the device, designed to aid in the diagnosis of 11 cancers, in the first half of 2022. OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval The company's cartridge for pneumonia for the Unyvero system is under review and pending approval by Chinese regulators. China NMPA Approves Illumina NextSeq 550Dx Sequencer for Genetic Testing and Diagnosis The clinical next-generation sequencing instrument is Illumina's second to receive approval from China's National Medical Products Administration. OpGen Posts 70 Percent Increase in Q3 Revenues Amid Shuffling of Portfolio The firm beat the consensus Wall Street estimate on the top line but fell short of the estimate on the bottom line. May 20, 2020 Genetron Health, Darui Strike Development Deal for Pathogen Sequencing Tests Mar 30, 2020 Rendu Biotechnology Gets Emergency Approval in China for Coronavirus Detection Kit Mar 26, 2020 Fosun Long March Gets Chinese Regulatory Approval for Coronavirus MDx Kit Feb 13, 2020 Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel Feb 11, 2020 Verigene II, New Assay Launches Anticipated to Revivify Luminex Revenues in 2020 Premium Feb 10, 2020 Luminex Q4 Revenues Rise 12 Percent Jan 29, 2020 BGI Sequencer, Coronavirus Molecular Assays Granted Emergency Use Approval in China Dec 2, 2019 Genetron Health Gets China NMPA Approval for Clinical NGS System, Files for IPO Nov 4, 2019 Biolidics ClearCell FX1 System Gets China NMPA Approval Jul 23, 2019 China's NMPA Extends Approval for Roche Cobas EGFR Mutation Test v2 to Plasma Samples Apr 11, 2019 Curetis 2018 Revenues Grow 17 Percent Mar 1, 2019 AmoyDx Wins Chinese Regulatory Approval for BRCA Mutation Test Feb 20, 2019 Burning Rock Dx to Seek Chinese Regulatory Approval for NGS Tests as it Eyes Early Cancer Detection Premium Dec 17, 2018 Mobidiag, Autobio Diagnostics to Form Joint Venture in China Oct 24, 2018 Agena Bioscience MassArray System Cleared by China FDA Aug 15, 2018 China FDA Approves Novogene CDx Test for NSCLC Therapies Jul 5, 2018 MGI Receives China FDA Registration for Sequencers May 3, 2018 HiberGene to Launch Three Multiplex Infectious Disease Tests by Year End; Seeks US Partner Premium Jan 26, 2018 CanHelp Pushes Gene Expression Tests Toward Clinical Approval in China Premium Jan 22, 2018 AmoyDx Wins Chinese Approval for Lung Cancer Liquid Biopsy CDx Load More Breaking News Ancient DNA Analysis Highlights Three Ancestral Populations in Japan FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.